PCN32 COST-EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN AS INITIAL ADJUVANT THERAPY IN HORMONE-RECEPTOR POSITIVE POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER IN THE UK
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67270-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67270-1/fulltext
Title :
PCN32 COST-EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN AS INITIAL ADJUVANT THERAPY IN HORMONE-RECEPTOR POSITIVE POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67270-1&doi=10.1016/S1098-3015(10)67270-1
First page :
Section Title :
Open access? :
No
Section Order :
500